View in EDS

FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.

Saved in:
Bibliographic Details
Title: FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.
Authors: Zhou L; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China., Barros E Silva MJ; A C Camargo Cancer Center, São Paulo, Brazil., Hsiao E; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia., Eroglu Z; H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Sandhu S; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Samoylenko I; N N Blokhin Russian Cancer Research Center, Moscow, Russian Federation., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia., Au-Yeung G; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Gonzalez M; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia., Pennington TE; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Chris O'Brien Lifehouse, Sydney, New South Wales, Australia., Kapoor R; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Burton EM; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tawbi HA; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Amaria RN; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Blank CU; Netherlands Cancer Center, Amsterdam, The Netherlands., Duprat JP; A C Camargo Cancer Center, São Paulo, Brazil., Brito de Paula R; A C Camargo Cancer Center, São Paulo, Brazil., Gyorki DE; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Ch'Ng S; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; NSW Health Pathology, Sydney, New South Wales, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; NSW Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Pires da Silva I; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Akkooi ACJV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia alexander.menzies@sydney.edu.au.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Mar 25; Vol. 13 (3). Date of Electronic Publication: 2025 Mar 25.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40132907
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhou+L%22">Zhou L</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Barros+E+Silva+MJ%22">Barros E Silva MJ</searchLink>; A C Camargo Cancer Center, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Hsiao+E%22">Hsiao E</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Eroglu+Z%22">Eroglu Z</searchLink>; H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Sandhu+S%22">Sandhu S</searchLink>; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Samoylenko+I%22">Samoylenko I</searchLink>; N N Blokhin Russian Cancer Research Center, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Lo+SN%22">Lo SN</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Carlino+MS%22">Carlino MS</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Au-Yeung+G%22">Au-Yeung G</searchLink>; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Gonzalez+M%22">Gonzalez M</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Spillane+AJ%22">Spillane AJ</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Pennington+TE%22">Pennington TE</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Shannon+KF%22">Shannon KF</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Kapoor+R%22">Kapoor R</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Burton+EM%22">Burton EM</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Tawbi+HA%22">Tawbi HA</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Amaria+RN%22">Amaria RN</searchLink>; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Blank+CU%22">Blank CU</searchLink>; Netherlands Cancer Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Duprat+JP%22">Duprat JP</searchLink>; A C Camargo Cancer Center, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Brito+de+Paula+R%22">Brito de Paula R</searchLink>; A C Camargo Cancer Center, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Gyorki+DE%22">Gyorki DE</searchLink>; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Saw+RPM%22">Saw RPM</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Ch'Ng+S%22">Ch'Ng S</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Rawson+RV%22">Rawson RV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; NSW Health Pathology, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Scolyer+RA%22">Scolyer RA</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; NSW Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Pires+da+Silva+I%22">Pires da Silva I</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Akkooi+ACJV%22">Akkooi ACJV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Menzies+AM%22">Menzies AM</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia alexander.menzies@sydney.edu.au.; Royal North Shore Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Mar 25; Vol. 13 (3). <i>Date of Electronic Publication: </i>2025 Mar 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40132907
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2025-011483
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhou L
      – PersonEntity:
          Name:
            NameFull: Barros E Silva MJ
      – PersonEntity:
          Name:
            NameFull: Hsiao E
      – PersonEntity:
          Name:
            NameFull: Eroglu Z
      – PersonEntity:
          Name:
            NameFull: Sandhu S
      – PersonEntity:
          Name:
            NameFull: Samoylenko I
      – PersonEntity:
          Name:
            NameFull: Lo SN
      – PersonEntity:
          Name:
            NameFull: Carlino MS
      – PersonEntity:
          Name:
            NameFull: Au-Yeung G
      – PersonEntity:
          Name:
            NameFull: Gonzalez M
      – PersonEntity:
          Name:
            NameFull: Spillane AJ
      – PersonEntity:
          Name:
            NameFull: Pennington TE
      – PersonEntity:
          Name:
            NameFull: Shannon KF
      – PersonEntity:
          Name:
            NameFull: Kapoor R
      – PersonEntity:
          Name:
            NameFull: Burton EM
      – PersonEntity:
          Name:
            NameFull: Tawbi HA
      – PersonEntity:
          Name:
            NameFull: Amaria RN
      – PersonEntity:
          Name:
            NameFull: Blank CU
      – PersonEntity:
          Name:
            NameFull: Duprat JP
      – PersonEntity:
          Name:
            NameFull: Brito de Paula R
      – PersonEntity:
          Name:
            NameFull: Gyorki DE
      – PersonEntity:
          Name:
            NameFull: Saw RPM
      – PersonEntity:
          Name:
            NameFull: Ch'Ng S
      – PersonEntity:
          Name:
            NameFull: Rawson RV
      – PersonEntity:
          Name:
            NameFull: Scolyer RA
      – PersonEntity:
          Name:
            NameFull: Pires da Silva I
      – PersonEntity:
          Name:
            NameFull: Akkooi ACJV
      – PersonEntity:
          Name:
            NameFull: Long GV
      – PersonEntity:
          Name:
            NameFull: Menzies AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 03
              Text: 2025 Mar 25
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1